Related references
Note: Only part of the references are listed.The current landscape of molecular profiling in the treatment of epithelial ovarian cancer
Carolyn E. Haunschild et al.
GYNECOLOGIC ONCOLOGY (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Caffeic acid phenethyl ester attenuates changes in pancreatic tissue damage biomarkers induced by cisplatin
Biljana Stosic et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2020)
Caffeic Acid Phenethyl Ester (CAPE) Induced Apoptosis in Serous Ovarian Cancer OV7 Cells by Deregulation of BCL2/BAX Genes
Anna Kleczka et al.
MOLECULES (2020)
Single-cell sequencing in ovarian cancer: a new frontier in precision medicine
Boris Winterhoff et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2019)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
Xuan Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Breaking the chains: deubiquitylating enzyme specificity begets function
Michael J. Clague et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models
Andrea Sartori et al.
CANCERS (2019)
Caffeic acid phenethyl ester potentiates gastric cancer cell sensitivity to doxorubicin and cisplatin by decreasing proteasome function
Toshiyuki Matsunaga et al.
ANTI-CANCER DRUGS (2019)
Ovarian cancer: screening and future directions
Keshav Kumar Gupta et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
Cristina Corno et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Alison E. Freimund et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response
Kanaka Durga Devi Gorrepati et al.
ISCIENCE (2018)
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
Paola Perego et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The Essential Medicinal Chemistry of Curcumin
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee et al.
PHARMACOLOGICAL RESEARCH (2017)
Real-world evidence in the treatment of ovarian cancer
E. A. Eisenhauer
ANNALS OF ONCOLOGY (2017)
Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells
Deepika Sharma Das et al.
CLINICAL CANCER RESEARCH (2017)
Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis
Claudia Gherman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Anionic glycolipids related to glucuronosyldiacylglycerol inhibit protein kinase Akt
Maria Vetro et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells
Giacomo Cossa et al.
CANCER LETTERS (2014)
UBE4B Protein Couples Ubiquitination and Sorting Machineries to Enable Epidermal Growth Factor Receptor (EGFR) Degradation
Natalie Sirisaengtaksin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Patient-reported outcomes in ovarian cancer clinical trials
M. L. Friedlander et al.
ANNALS OF ONCOLOGY (2013)
New 6-amino-6-deoxy-glycoglycerolipids derived from 2-O-β-D-glucopyranosylglycerol: insights into the structure-activity relationship of glycoglycerolipids as anti-tumor promoters
Diego Colombo et al.
CARBOHYDRATE RESEARCH (2013)
The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation
Inez M. J. Meijer et al.
CELLULAR SIGNALLING (2013)
USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
Sanguine Byun et al.
CLINICAL CANCER RESEARCH (2013)
Caffeic Acid Phenethyl Ester Suppresses the Proliferation of Human Prostate Cancer Cells through Inhibition of p70S6K and Akt Signaling Networks
Chih-Pin Chuu et al.
CANCER PREVENTION RESEARCH (2012)
The pharmacology of curcumin: is it the degradation products?
Liang Shen et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
Laura Gatti et al.
BMC GENOMICS (2011)
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Euan A. Stronach et al.
CANCER RESEARCH (2011)
The USP1/UAF1 Complex Promotes Double-Strand Break Repair through Homologous Recombination
Junko Murai et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Ubiquitin-Specific Protease 8 Links the PTEN-Akt-AIP4 Pathway to the Control of FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme
Amith Panner et al.
CANCER RESEARCH (2010)
Strategies to Improve the Efficacy of Platinum Compounds
Giacomo Cossa et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
Bharat B. Aggarwal et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Characterization of three new serous epithelial ovarian cancer cell lines
Veronique Ouellet et al.
BMC CANCER (2008)
Click chemistry, a powerful tool for pharmaceutical sciences
Christopher D. Hein et al.
PHARMACEUTICAL RESEARCH (2008)
Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1
Zhongwei Cao et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation
PE Row et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Global gene expression of fission yeast in response to cisplatin
L Gatti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells
P Perego et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death
JE Mullally et al.
MOLECULAR PHARMACOLOGY (2002)
Share Paper
